Orgenesis (FRA:45O0) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Orgenesis ROE % Adjusted to Book Value?

Orgenesis's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Orgenesis's PB Ratio for the quarter that ended in Sep. 2024 was N/A. Orgenesis's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

Orgenesis ROE % Adjusted to Book Value Historical Data

The historical data trend for Orgenesis's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis ROE % Adjusted to Book Value Chart

Orgenesis Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

1.79

-25.21

-27.05

Orgenesis Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-54.45	-	-	-	-

Competitive Comparison of Orgenesis's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Orgenesis's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orgenesis's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Orgenesis's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Orgenesis ROE % Adjusted to Book Value Calculation

Orgenesis's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1,498.19%	/	N/A
	=	N/A

Orgenesis's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Orgenesis ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Orgenesis's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O0) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ORGS:USA

Address

20271 Goldenrod Lane, Germantown, MD, USA, 20876

Website

https://www.orgenesis.com

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.

Orgenesis Headlines

No Headlines